Explaining juvenile idiopathic arthritis to paediatric patients using illustrations and easy-to-read texts:

Christiane Reiser1, Nina A Zeltner2, Beatrix Rettenbacher3

  • 1Department of Paediatrics, LKH Bregenz, Bregenz, Austria. Christiane.reiser@lkhb.at.

Insights

Newly developed educational materials significantly improved disease knowledge and self-efficacy in children with juvenile idiopathic arthritis (JIA). These easy-to-read resources, featuring custom illustrations, aim to enhance patient understanding and adherence to JIA therapy.

Area of Science:

  • Pediatric Rheumatology
  • Medical Education
  • Health Communication

Background:

  • Juvenile idiopathic arthritis (JIA) is a prevalent chronic rheumatic condition in children.
  • Effective JIA management necessitates a thorough understanding of the disease and its treatment options for improved patient adherence.

Purpose of the Study:

  • To develop and evaluate specifically designed illustrations and standardized, easy-to-read texts for educating children and adolescents with JIA.
  • To assess the comprehensibility and content validity of these educational materials.
  • To test the hypothesis that these materials would increase children's knowledge about JIA.

Main Methods:

  • Illustrations were created by a graphic artist, and informative texts were simplified into easy-to-read language.
  • A modular system was employed to allow for individualized patient information.
  • The materials were tested for knowledge gain and self-efficacy improvement in children with JIA and control groups, with health-related quality of life (HRQoL) also assessed.

Main Results:

  • Testing involved 38 JIA patients and 46 controls (median age 11 years).
  • Both groups showed significant knowledge gain post-intervention (p < 0.001).
  • Patients demonstrated a greater enhancement in self-efficacy, and no negative impact on HRQoL was observed.

Conclusions:

  • Developing clear, jargon-free explanations of juvenile rheumatic diseases and treatments is crucial in pediatric rheumatology.
  • Custom illustrations and simplified texts effectively improve disease knowledge in both JIA patients and healthy children.
  • The developed educational materials enhance self-efficacy in pediatric patients and support therapeutic adherence.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
90
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
821
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
54
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.6K